Adalimumab vs Insulin Glargine

## Adalimumab vs Insulin Glargine: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Insulin Glargine**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Insulin Glargine**: Long-acting insulin analogue that binds insulin receptors.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Insulin Glargine — 12-24 hours.

## Chemical Properties

**Type**: Adalimumab — Antibody; Insulin Glargine — Protein.